The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by King Richard since 2005.
The trader's CIK number is 1013702.
At the time of the last reporting, King Richard was the EVP, Commercial Oper of Adamas Pharmaceuticals Inc. (stock ticker symbol ADMS).
Also see all insider trading activities at Adamas Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | KOSP | 0 | $0 | 10,000 | $500,000 | 10,000 | $195,000 |
| 2005 | KOSP | 0 | $0 | 3,000 | $214,020 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ADMS | 0 | $0 | 2,501 | $63,725 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | ACRX | 3,500 | $15,959 | 0 | $0 | 0 | $0 |
1. Kos Pharmaceuticals Inc (KOSP)
2. Adamas Pharmaceuticals Inc (ADMS)
3. Acelrx Pharmaceuticals Inc (ACRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-02-16 | KOSP | Sale | 5,000 | 50.00 | 250,000 |
| 2006-02-16 | KOSP | Option Ex | 5,000 | 19.50 | 97,500 |
| 2006-03-10 | KOSP | Sale | 5,000 | 50.00 | 250,000 |
| 2006-03-10 | KOSP | Option Ex | 5,000 | 19.50 | 97,500 |
| 2005-08-01 | KOSP | Sale | 3,000 | 71.34 | 214,020 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-06-21 | ADMS | Sale | 2,501 | 25.48 | 63,725 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-06-09 | ACRX | Buy | 3,500 | 4.56 | 15,959 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by King Richard (EVP, Commercial Oper of Adamas Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.